ZIMMER BIOMET HOLDINGS, INC. - 8-K Filing

Zimmer Biomet reports Q3 2026 net sales of $2.063 billion and raises full-year organic constant-currency revenue and adjusted EPS guidance. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ZBH

Read the full article at SEC EDGAR

More Regulatory news